These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30444586)

  • 21. Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Grosjean-Raillard J; Adès L; Boehrer S; Tailler M; Fabre C; Braun T; De Botton S; Israel A; Fenaux P; Kroemer G
    Apoptosis; 2008 Sep; 13(9):1148-61. PubMed ID: 18670883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
    Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
    Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
    Winfield DA; Polacarz SV
    J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
    [No Abstract]   [Full Text] [Related]  

  • 24. Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing a unique long terminal repeat.
    Hisasue M; Nagashima N; Nishigaki K; Fukuzawa I; Ura S; Katae H; Tsuchiya R; Yamada T; Hasegawa A; Tsujimoto H
    Int J Cancer; 2009 Mar; 124(5):1133-41. PubMed ID: 19035458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia.
    Handa H; Nishimoto N; Inoue M; Yokohama A; Tsukamoto N; Saitoh T; Murakami H
    Hematol Oncol; 2019 Oct; 37(4):520-522. PubMed ID: 30990910
    [No Abstract]   [Full Text] [Related]  

  • 26. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extramedullary initial manifestations of acute myeloid leukemia (AML)].
    Schmitt-Gräff A; Wickenhauser C; Kvasnicka HM; Dries V; Thiele J
    Pathologe; 2002 Nov; 23(6):397-404. PubMed ID: 12436291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies.
    Bartl R; Frisch B; Baumgart R
    Leuk Res; 1992; 16(1):15-33. PubMed ID: 1732665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents.
    Casellas Román HL; Venugopal K; Feng Y; Shabashvili DE; Posada LM; Li J; Guryanova OA
    Leuk Res; 2020 Jul; 94():106372. PubMed ID: 32445940
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
    Radujkovic A; Dietrich S; Andrulis M; Benner A; Longerich T; Pellagatti A; Nanda K; Giese T; Germing U; Baldus S; Boultwood J; Ho AD; Dreger P; Luft T
    Int J Cancer; 2016 Sep; 139(6):1402-13. PubMed ID: 27170453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A histopathological study of bone marrow in acute myeloid leukemia. Bone marrow biopsy changes before chemotherapy and comparison with bone marrow smears].
    Pu Q; Tang CS; Zhou RH
    Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):566-8, 595. PubMed ID: 1806340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes.
    Wimazal F; Sperr WR; Kundi M; Vales A; Fonatsch C; Thalhammer-Scherrer R; Schwarzinger I; Valent P
    Ann Oncol; 2008 May; 19(5):970-6. PubMed ID: 18272915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Choroid infiltration in myelodysplastic syndrome].
    Madjlessi F; Dann K; Althaus C; Sundmacher R; Meckenstock G
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):51-4. PubMed ID: 9743940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.
    Iwata M; Pillai M; Ramakrishnan A; Hackman RC; Deeg HJ; Opdenakker G; Torok-Storb B
    Blood; 2007 Jan; 109(1):85-92. PubMed ID: 16954500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow cell cycle markers in inherited bone marrow failure syndromes.
    Al-Rahawan MM; Alter BP; Bryant BJ; Elghetany MT
    Leuk Res; 2008 Dec; 32(12):1793-9. PubMed ID: 18606449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes.
    Voso MT; Scardocci A; Guidi F; Zini G; Di Mario A; Pagano L; Hohaus S; Leone G
    Blood; 2004 Jan; 103(2):698-700. PubMed ID: 14504087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia.
    Feldman EJ; Seiter KP; Ahmed T; Baskind P; Arlin ZA
    Leukemia; 1996 Jan; 10(1):40-2. PubMed ID: 8558935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.